These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11406777)

  • 1. The efficacy of whole cell pertussis immunisation: collected data on a vaccine produced in France.
    Fletcher MA; Saliou P; Ethevenaux C; Plotkin SA
    Public Health; 2001 Mar; 115(2):119-29. PubMed ID: 11406777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines.
    Olin P; Rasmussen F; Gustafsson L; Hallander HO; Heijbel H
    Lancet; 1997 Nov; 350(9091):1569-77. PubMed ID: 9393335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis vaccine controversies and acellular pertussis vaccine.
    Shah RC; Shah AR
    Indian J Pediatr; 2003 Jun; 70(6):485-8. PubMed ID: 12921317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-cell and acellular pertussis vaccines.
    Wintermeyer SM; Nahata MC; Kyllonen KS
    Ann Pharmacother; 1994; 28(7-8):925-39. PubMed ID: 7949515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies on efficacy and safety of acellular pertussis vaccine.
    Isomura S
    Tokai J Exp Clin Med; 1988; 13 Suppl():39-43. PubMed ID: 3078809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in pertussis immunisation in Japan.
    Kimura M; Kuno-Sakai H
    Lancet; 1990 Jul; 336(8706):30-2. PubMed ID: 1973217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use--supplementary ACIP statement. Recommendations of the Immunization Practices Advisory Committee (ACIP).
    MMWR Recomm Rep; 1992 Feb; 41(RR-1):1-10. PubMed ID: 1741009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age.
    Langue J; Matisse N; Pacoret P; Undreiner F; Boisnard F; Soubeyrand B;
    Vaccine; 2004 Mar; 22(11-12):1406-14. PubMed ID: 15063563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do pertussis vaccines fail?
    Cherry JD
    Pediatrics; 2012 May; 129(5):968-70. PubMed ID: 22529282
    [No Abstract]   [Full Text] [Related]  

  • 16. Acellular pertussis vaccines: new preparation. Better tolerated but less active?
    Prescrire Int; 2000 Feb; 9(45):204-7. PubMed ID: 11503797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acellular vaccines for preventing whooping cough in children.
    Zhang L; Prietsch SO; Axelsson I; Halperin SA
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001478. PubMed ID: 21249646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acellular pertussis vaccine: recommendations for use as the initial series in infants and children. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1997 Feb; 99(2):282-8. PubMed ID: 9024463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis immunisation in adolescents and adults--Bordetella pertussis epidemiology should guide vaccination recommendations.
    Heininger U; Cherry JD
    Expert Opin Biol Ther; 2006 Jul; 6(7):685-97. PubMed ID: 16805708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.